β-Adrenergic and Atrial Natriuretic Peptide Interactions on Human Cardiovascular and Metabolic Regulation
Open Access
- 1 December 2006
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 91 (12) , 5069-5075
Abstract
Context: Atrial natriuretic peptide (ANP) has well-known cardiovascular effects and modifies lipid and carbohydrate metabolism in humans. Objective: The objective of the study was to determine the metabolic and cardiovascular interaction of β-adrenergic receptors and ANP. Design: This was a crossover study, conducted 2004–2005. Setting: The study was conducted at an academic clinical research center. Patients: Patients included 10 healthy young male subjects (body mass index 24 ± 1 kg/m2). Intervention: We infused iv incremental ANP doses (6.25, 12.5, and 25 ng/kg·min) with and without propranolol (0.20 mg/kg in divided doses followed by 0.033 mg/kg·h infusion). Metabolism was monitored through venous blood sampling, im, and sc microdialysis and indirect calorimetry. Cardiovascular changes were monitored by continuous electrocardiogram and beat-by-beat blood pressure recordings. Main Outcome Measures: Venous nonesterified fatty acid, glycerol, glucose, and insulin; and microdialysate glucose, glycerol, lactate, and pyruvate were measured. Results: ANP increased heart rate dose dependently. β-Adrenergic receptor blockade abolished the response. ANP elicited a dose-dependent increase in serum nonesterified fatty acid and glycerol concentrations. The response was not suppressed with propranolol. Venous glucose and insulin concentrations increased with ANP, both without or with propranolol. ANP induced lipid mobilization in sc adipose tissue. In skeletal muscle, microdialysate lactate increased, whereas the lactate to pyruvate ratio decreased, both with and without propranolol. Higher ANP doses increased lipid oxidation, whereas energy expenditure remained unchanged. Propranolol tended to attenuate the increase in lipid oxidation. Conclusions: Selected cardiovascular ANP effects are at least partly mediated by β-adrenergic receptor stimulation. ANP-induced changes in lipid mobilization and glycolysis are mediated by another mechanism, presumably stimulation of natriuretic peptide receptors, whereas substrate oxidation might be modulated through adrenergic mechanisms.Keywords
This publication has 39 references indexed in Scilit:
- Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exerciseAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolismCell Metabolism, 2005
- Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat CellsThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Impact of Obesity on Plasma Natriuretic Peptide LevelsCirculation, 2004
- Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese womenInternational Journal of Obesity, 2002
- Microdialysis in Adipose Tissue and Skeletal MuscleHormone and Metabolic Research, 1997
- Wasting as independent risk factor for mortality in chronic heart failureThe Lancet, 1997
- Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissueTrends in Pharmacological Sciences, 1996
- The ethanol technique of monitoring local blood flow changes in rat skeletal muscle: implications for microdialysisActa Physiologica Scandinavica, 1992
- Interactions between atrial natriuretic factor and the autonomic nervous systemClinical Autonomic Research, 1991